Multiple Risk Factor Intervention Trial Revisited: A New Perspective Based on Nonfatal and Fatal Composite Endpoints, Coronary and Cardiovascular, During the Trial
Journal of the American Heart Association. Cardiovascular and cerebrovascular disease